# Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System

> **NCT07687485** · NA · NOT_YET_RECRUITING · sponsor: **Laplace Interventional, Inc** · enrollment: 700 (estimated)

## Conditions studied

- Severe Tricuspid Valve Regurgitation
- Tricuspid Valve Regurgitation
- Tricuspid Valve Disease
- Cardiovascular Diseases (CVD)
- Heart Valve Diseases
- Tricuspid Valve Insufficiency
- Severe Heart Valve Disease
- Symptomatic Tricuspid Regurgitation

## Interventions

- **DEVICE:** Transcatheter Tricuspid Valve Replacement (TTVR) with Laplace TTVR System
- **DEVICE:** Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE TTVR System

## Key facts

- **NCT ID:** NCT07687485
- **Lead sponsor:** Laplace Interventional, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2029-09
- **Final completion:** 2038-09
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687485, "Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07687485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*